Carmel Capital Partners, LLC Pfizer Inc Transaction History

Carmel Capital Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$32.09 - $37.51 $67,485 - $78,883	2,103 Added 324.54%	2,751 $91,000
Q2 2023 Jul 27, 2023	SELL	$36.12 - $41.79 $94,742 - $109,615	-2,623 Reduced 80.19%	648 $23,000
Q1 2023 Apr 19, 2023	SELL	$39.39 - $51.28 $147,554 - $192,094	-3,746 Reduced 53.38%	3,271 $133,000
Q4 2022 Jan 17, 2023	SELL	$41.75 - $54.5 $178,940 - $233,587	-4,286 Reduced 37.92%	7,017 $0
Q2 2022 Jul 11, 2022	SELL	$46.53 - $55.17 $114,696 - $135,994	-2,465 Reduced 17.9%	11,303 $593,000
Q1 2022 Apr 18, 2022	SELL	$45.75 - $56.69 $11,940 - $14,796	-261 Reduced 1.86%	13,768 $713,000
Q4 2021 Jan 31, 2022	BUY	$41.32 - $61.25 $579,678 - $859,276	14,029 New	14,029 $828,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Carmel Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Carmel Capital Partners, LLC with notifications on news.